Difference between revisions of "Nu-Vois"

From HCE Wiki - The Human Cognitive Enhancement Wiki
Jump to: navigation, search
(dates; purpose; treatment)
(policy)
Line 36: Line 36:
  
 
== Ethical & Health Issues ==
 
== Ethical & Health Issues ==
<!-- Provide detailed information (if possible or if available) about any ethical risks and related ethical topics, and also related health issues, be it already discovered and covered in literature, or just speculative ones, should be described and properly cited in this section. -->
+
 
 +
There are no ethical or health issues connected to this particular device.
 +
 
 +
For more general issues connected with smartglasses, please see the [[Electrolarynx]] synopsis.  
  
 
== Public & Media Impact and Presentation ==
 
== Public & Media Impact and Presentation ==
Line 42: Line 45:
  
 
== Public Policy ==
 
== Public Policy ==
<!-- Information related to any regulations (law, patents, ISOs, government recommendations and so on.) -->
+
 
 +
As of 2016, Nu-Vois LLC is registered with the U.S. Food and Drug Administration under the Registration Number 3029791.<ref>http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?rid=48675</ref>
  
 
== Related Technologies, Projects or Scientific Research ==
 
== Related Technologies, Projects or Scientific Research ==
<!-- If there is any scientific research conducted or being conducted that is closely connected to this technology, it should be properly cited here. -->
+
 
 +
There are no related projects or research relevant to this device specifically.
 +
 
 +
For more information about this type of devices, please see the [[Electrolarynx]] synopsis.  
  
 
== References ==
 
== References ==

Revision as of 11:11, 8 February 2016

http://www.nu-vois.com/


Main characteristics

The company offers a selection of electrolarynxes ranging from their earliest model Nu-Vois I, through Nu-Vois II, III, and a smaller model that should serve as a backup device the Xtra-Vois. All the devices are roughly the same in size, shape, weight. The models have tubular shape 33 mm in diameter, weight approximately 120 g, and are 112 mm long. All are designed to be operated with one hand with the thumb operating the buttons. Detailed descriptions of the individual devices follow:

Nu-Vois I[1] is the most basic and the oldest device Nu-Vois produces. It features an on/off button and a volume adjusting thumb wheel. The user can also adjust the pitch of the produced sound with a small screw accessible externally. A small screwdriver required for the task is included with the device.[2] The device costs ### USD.

Nu-Vois II[1] is a next iteration on the previous model. It was released in 1999. It features the same controls as the previous model sans the volume thumb wheel. All tonal adjustments are done incrementally via two buttons. The settings can be stored digitally.[3] The device costs ### USD.

Nu-Vois III[4] is the latest and comparably most advanced model. It features 4 buttons - two to lower or increase the volume, and two to turn the device on and off. The second group of buttons is also used to store and recall saved settings. The user can then have two different settings for pitch and volume ready to be used.[5][6] The device costs ### USD.

Xtra-Vois I[7] is a basic model that should serve as a backup device. It does not feature an advanced controls for pitch. The device is otherwise identical in features to Nu-Vois I.[8][9]

All devices come with oral tubes and two 9 V NiMH rechargeable batteries included.

Purpose

The series of devices is directed towards laryngectomy patients that lost their ability to produce speech. The usage of an electrolarynxs allows the to communicate in a quick and natural manner without resorting to other means such as pen and paper.

Company & People

Nu-Vois LLC is an American electronics company located in Meridian, Idaho.[10] The company claims to be on the market for over 20 years but did not indicated the date it was established.

Important Dates

  • 1999 - Nu-Vois LLC introduces the Nu-Vois II.[10]
  • 2000 - Nu-Vois LLC introduces Nu-Vois III.[10]

Enhancement/Therapy/Treatment

Treatment - Electrolarynxes are meant to return the ability to communicate by voice for laryngectomy patients.

Ethical & Health Issues

There are no ethical or health issues connected to this particular device.

For more general issues connected with smartglasses, please see the Electrolarynx synopsis.

Public & Media Impact and Presentation

Public Policy

As of 2016, Nu-Vois LLC is registered with the U.S. Food and Drug Administration under the Registration Number 3029791.[11]

Related Technologies, Projects or Scientific Research

There are no related projects or research relevant to this device specifically.

For more information about this type of devices, please see the Electrolarynx synopsis.

References

  1. 1.0 1.1 http://www.nu-vois.com/nuvois1and2.php
  2. http://www.luminaud.com/nu_vois_i
  3. http://www.electrolarynx.com/pages/catalog/ElectroLarynges.html
  4. http://www.nu-vois.com/nuvois3.php
  5. http://www.luminaud.com/nu_vois_iii
  6. http://speech-language-pathology-audiology.advanceweb.com/Article/NU-VOIS-Electronic-Speech-Prostheses.aspx
  7. http://www.nu-vois.com/accessories.php
  8. http://www.luminaud.com/xtra_vois
  9. http://www.brucemedical.com/xtravois.html
  10. 10.0 10.1 10.2 http://www.nu-vois.com/about.php
  11. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?rid=48675